Connect with us

Technology

ixlayer and Ipsos’ “ixInsights 2025” Study Reveals Consumer Expectations for Digital Health and Pharma’s Role in Enhancing Patient Experience

Published

on

Study Captures Drivers and Deterrents to Digital Health to Inform Biopharma Cx, Commercialization and Marketing Efforts

SAN FRANCISCO, April 1, 2025 /PRNewswire/ — ixlayer, a leading cloud-based healthtech platform, with Ipsos, a global leader in market research, have released findings from the inaugural research report, “ixlayer ixInsights 2025: Pharma’s Role in Improving the Health Experience.” The study looks at patients with specific conditions–asthma, COPD, type 2 diabetes, heart disease, psoriasis, or atopic dermatitis–to identify their experiences, motivations and barriers to digital health adoption. More importantly, it looks ahead outlining actionable insight and drivers to enhance biopharma’s customer experience (Cx), commercialization and marketing efforts.

To view the complete “ixlayer ixInsights 2025” study by Ipsos, email contact@ixlayer.com to request a copy.

A resounding 74% of surveyed patients would value help from a pharmaceutical company to reduce their healthcare barriers. These findings explore the health solutions these patients are looking for and the positive impact on the perception of the pharma companies that offer them.

In fact, 8 in 10 patients in this survey said that pharmaceutical companies should provide resources to help them get the care and medicines they need (81%). The report highlights consumers’ strong demand for various digital health solutions from pharma including patient assistance, affordability, easier access to lab testing, tools to help access medication and telehealth services. Consumer sentiment aligns with the 83% of U.S. physicians across specialties that believe at-home diagnostic tests help move patients through the care continuum faster, leading to earlier diagnosis and treatment to support better health, according to a separate 2024 survey of U.S. physicians.

“The expansion of DTC initiatives and services leveraging digital technology for pharma is a hot topic among the biopharma leaders we meet with, and partnering with Ipsos allowed us to uncover the real challenges and opportunities shaping the future of this emerging model,” explained Pouria Sanae, co-founder and CEO, ixlayer. “This survey confirms that patients don’t just want treatment from pharma—they want seamless, digital-first healthcare experiences that fit into their lives.”

“It is crucial for all stakeholders to focus on integrating and developing tools that put patients at the core,” explained Chareen Lim, SVP of Ipsos Healthcare. “The journey towards a seamless patient experience is ongoing, and this study shows there are ample opportunities to innovate and improve within this young and dynamic sector.”

Excerpted data: “ixlayer ixInsights 2025: Pharma’s Role in Improving the Health Experience”

Current adoption is strong, with room for technical improvementsMore than 3 out of 4 respondents agree that digital health solutions have helped maintain better communication with their healthcare providers (77%)They believe that it’s a cost effective way to maintain their health (73%)27% report having technical difficulties when using digital health solutions50% have to use multiple digital health platformsTop digital health solutions 92% of surveyed patients use or have used patient portals for accessing healthcare information and resources82% use or have used telehealth platforms for virtual consultations67% use or have used pharmacy delivery services65% use or have used wearable devices for health62% use or have used at-home diagnostic testing kitsThese patients want pharma to do more 81% of respondents believe pharmaceutical companies should provide resources to help them access care and medicationsOnly 16% strongly believes pharma prioritizes their needsAttributes of digital health services poised to drive usageAbility to consult with healthcare professionals virtually or schedule in person83% of respondents report a likelihood to useAccept insurance coverage for services83% report a likelihood to useSecure options for sharing your health data (e.g., lab test results) with others including your healthcare provider79% report a likelihood to useEasier access for lab testing, at-home kits, or scheduling at service center78% report a likelihood to useProvides digital pharmacy options (e.g., online ordering, prescription delivery)74% report a likelihood to use92% of surveyed patients say their perception of pharma would improve if they offered at least one of the following digital health solutions, including:Ability to consult with healthcare professionals virtually or schedule in person78% say it would improve their perception of pharmaAccept insurance coverage for services83% say it would improve their perception of pharmaSecure options for sharing your health data (e.g., lab test results) with others including your healthcare provider77% say it would improve their perception of pharmaEasier access for lab testing, at-home kits, or scheduling at service center78% say it would improve their perception of pharmaProvides digital pharmacy options (e.g., online ordering, prescription delivery)74% say it would improve their perception of pharma

The study captures consumer sentiment for what’s working and what’s not in digital health. Their top reasons for satisfaction with digital health are: convenience, improved communication with healthcare providers, quicker access to treatment or care, and easier access to the medications they need. The top reasons for dissatisfaction with digital health are: the need to use multiple platforms to get what they need, technical issues, and concerns about data security.

The rise of digital health, telemedicine, and direct-to-patient platforms highlights the growing demand for technology-driven healthcare solutions. As consumers increasingly expect these innovations, the survey findings signal a critical opportunity for pharma to strengthen its relationship with patients. Companies that prioritize patient-centric, digital solutions will be well-positioned to lead in the evolving healthcare ecosystem.

About ixlayer

ixlayer [pronounced: I-X-layer] is the leading provider of cloud-based platforms that power a seamless, end-to-end direct-to-patient healthcare experience. The name reflects our core strength: “i” for robust data and technology infrastructure and “x” for exceptional user experience. ixEngage by ixlayer seamlessly integrates with all healthcare ecosystem partners, connecting biopharma with patients in a user-centric way. This proprietary technology accelerates the path to diagnoses, supports optimal care, drives operational efficiency, and improves health equity and outcomes for all. To date, ixlayer has activated over four million patient care journeys, simplifying the complex web of healthcare. Learn more at www.ixlayer.com.

About Ipsos

Ipsos is one of the largest market research and polling companies globally, operating in 90 markets and employing over 18,000 people.

Our passionately curious research professionals, analysts and scientists have built unique multi-specialist capabilities that provide true understanding and powerful insights into the actions, opinions and motivations of citizens, consumers, patients, customers or employees. Our 75 solutions are based on primary data from our surveys, social media monitoring, and qualitative or observational techniques.

Our tagline “Game Changers” sums up our ambition to help our 5,000 customers move confidently through a rapidly changing world.

Founded in France in 1975, Ipsos has been listed on the Euronext Paris since July 1, 1999. The company is part of the SBF 120 and Mid-60 indices and is eligible for the Deferred Settlement Service (SRD). ISIN code FR0000073298, Reuters ISOS.PA, Bloomberg IPS:FP www.ipsos.com

Survey Methodology
These are some of the findings of an ixlayer patient survey, with data collection done by Ipsos. A total of n=414 individuals, ages 21+, with at least one of the following conditions was surveyed online between January 6-24, 2025: asthma, COPD, type 2 diabetes, heart disease, psoriasis, or atopic dermatitis. Some quotas were placed around respondent age in order to achieve a nearly even split of baby boomer, Gen X, and millennial respondents. No weights were applied to the data, and the findings reflect the opinion of these survey respondents only. 

View original content to download multimedia:https://www.prnewswire.com/news-releases/ixlayer-and-ipsos-ixinsights-2025-study-reveals-consumer-expectations-for-digital-health-and-pharmas-role-in-enhancing-patient-experience-302416443.html

SOURCE ixlayer

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

Changes in UPM’s Group Executive Team: Joonas Rauramo appointed Executive Vice President, UPM Energy

Published

on

By

UPM-Kymmene Corporation Stock Exchange Release (Changes board/management/auditors) June 3, 2026 at 10:00 EEST

HELSINKI, June 3, 2026 /PRNewswire/ — Joonas Rauramo has been appointed Executive Vice President, UPM Energy. He will be a member of UPM’s Group Executive Team and report to Massimo Reynaudo, President and CEO. He will assume his role on October 1, 2026 and will be based in Helsinki, Finland.

Rauramo, born in 1983, will join UPM from Coolbrook Oy where he has served as CEO since 2022 and prior to that as Executive Vice President, Strategy & Industrial Partnerships. From 2007 to 2021, he held various roles at Fortum, most recently as Vice President, Wind and as Vice President, Solar & Wind Development. He serves as a board member at Korkia, and as a member of the IEA Technology and Innovation Advisory Board. Rauramo has Master of Science in Technology from Helsinki University of Technology and Master of Science in Economics from Aalto University School of Economics. He is a Finnish citizen.

“I’m delighted to welcome Joonas to UPM. He brings extensive experience in power generation and industrial decarbonisation, as well as deep expertise in energy markets, project financing, M&A and building global partnerships. These are capabilities that are increasingly critical as demand for reliable, emission-free electricity continues to grow and the energy system undergoes profound transformation. With Joonas on board, we continue to develop our energy business further and contribute to the transition towards a sustainable and resilient energy future,” says Massimo Reynaudo.

UPM, Media relations
Mon-Fri 9:00-16:00 EEST
tel. +358 40 588 3284
media@upm.com

UPM

UPM is a material solutions company, renewing products and entire value chains with an extensive portfolio of renewable fibres, advanced materials, decarbonization solutions, and communication papers. Our performance in sustainability has been recognized by third parties, including EcoVadis and the Dow Jones Sustainability Indices. We operate globally and employ approximately 15,100 people worldwide, with annual sales of approximately €9.7 billion. Our shares are listed on Nasdaq Helsinki Ltd.
UPM – we renew the everyday
Read more: upm.com 

Follow us on LinkedIn | YouTube | Instagram | #UPM #materialsolutions #WeRenewTheEveryday 

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/upm-kymmene-oyj/r/changes-in-upm-s-group-executive-team–joonas-rauramo-appointed-executive-vice-president–upm-energy,c4356924

The following files are available for download:

 

View original content:https://www.prnewswire.co.uk/news-releases/changes-in-upms-group-executive-team-joonas-rauramo-appointed-executive-vice-president-upm-energy-302789862.html

Continue Reading

Technology

Helsinki Invites International Companies to Explore R&D Partnerships in Life Sciences and AI & Deep Tech

Published

on

By

HELSINKI, June 3, 2026 /PRNewswire/ — Helsinki Partners, together with the City of Helsinki and the University of Helsinki, is inviting international companies to explore research and development partnerships at two of the city’s leading innovation environments. Through the 90 Hour Helsinki Program, senior decision makers from established companies and scaleups are currently exploring Finland’s business ecosystem over three intensive days, meeting relevant organisations and exploring partnership opportunities for AI & Deep Tech R&D.

For many international companies, R&D expansion comes with real barriers: lack of specialist talent, limited access to laboratory or cleanroom space, and the high cost of building local infrastructure. Helsinki innovation partnerships address these challenges directly – instead of investing heavily in facilities and hiring from scratch, companies can get straight to work with partner organisations, researchers, and thesis students.

Helsinki’s innovation clusters drive global breakthroughs

The 90 Hour Helsinki Program gives access to two university-driven innovation clusters: Viikki is a leading ecosystem for life sciences, biotech, and sustainability, and Kumpula for AI and deep tech research. Both clusters align with the University of Helsinki’s Future Technologies research area, which emphasises responsible and ethical approaches to new technologies.

“Our research is rooted in both scientific excellence and responsibility,” said Jouni Hirvonen, Vice-Rector of Innovation, Infrastructures and Facilities at the University of Helsinki. “Collaborating with international companies allows us to commercialise and scale innovations that both advance technology and contribute to sustainable and ethical solutions for society.”

Organisations active across the clusters include the Natural Resources Institute Finland, HiLIFE, the Ellis Institute, the Finnish Center for Artificial Intelligence (FCAI), and the LUMI AI Factory. Participants choose the track most relevant to their business and spend the day with researchers, companies, and ecosystem partners on that campus.

R&D without the upfront investment

Finland’s R&D funding landscape and cost-efficient operating environment make Helsinki one of the most practical locations in Europe for early-stage collaboration. For companies outside of the EU region, the city offers a stable European base at a time when trade conditions are shifting, with direct flight connections to major cities across Asia and Americas.

“Helsinki offers a unique environment where companies can directly engage with top research, advanced facilities, emerging talent, and the exciting startup culture,” said Heidi Humala, Director, Business Environment at Business Helsinki, City of Helsinki. “Through close collaboration, Helsinki enables private companies to accelerate their R&D without the need for heavy upfront investments.”

Innovation partnerships in practice

ASM, a global leader in semiconductor equipment, has been working with the University of Helsinki for more than two decades. The company expanded its collaboration in 2022 with the launch of the ALD Center of Excellence, a new centre focused on developing advanced materials for next-generation microchips used in AI systems, medical devices, and energy-efficient electronics.

This long-term partnership is one example of the public-private co-innovation that Helsinki supports, and that the 90 Hour Helsinki Program is designed to build.

“Helsinki is known for its trust-based business culture and functional public–private partnerships,” said Clarisse Berggårdh, CEO at Helsinki Partners. “By joining the 3-day 90 Hour Helsinki Program, companies can experience this culture firsthand and start building meaningful collaborations.”

Applications are now open for the 90 Hour Helsinki Program taking place 28–30 September, 2026. The application period closes on 14 August, 2026.

Read more and apply here.

                                   

                                   

Facts at a glance                           

                                               

•  Helsinki is the most cost-efficient city in Europe for biotech and pharma R&D

                                               

•  The Helsinki region ranks 1st in the EU for innovative SMEs collaborating with others

                                               

•  The region also leads in R&D expenditure in the business sector and international scientific co-publications

                                               

•  The University of Helsinki ranks in the top 1% of universities globally

                                               

•  ASM‘s partnership with the University of Helsinki spans more than 20 years

                                   

                                     

                                   

For more information, please contact:

Eelis Torvinen
Marketing & Communications Manager, Helsinki Partners
eelis.torvinen@helsinkipartners.com

Sonja Malin
Senior Advisor, Helsinki Partners
sonja.malin@helsinkipartners.com
+358 400 175 636

About the 90 Hour Helsinki Program and Helsinki Partners

The 90 Hour Helsinki Program, organised by Helsinki Partners, gives senior decision makers direct access to Helsinki’s life sciences and deep tech ecosystems over three intensive days. The programme includes briefings on the Finnish business environment, visits to research organisations and companies, and tailored meetings across the Viikki and Kumpula campuses. Helsinki Partners covers accommodation during the programme for up to four days for one representative per company.

Helsinki Partners is the City of Helsinki’s international investment promotion and city marketing company, providing free expansion services for businesses looking to establish a presence in Finland.

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/helsinki-partners/r/helsinki-invites-international-companies-to-explore-r-d-partnerships-in-life-sciences-and-ai—deep-,c4356274

The following files are available for download:

View original content:https://www.prnewswire.com/apac/news-releases/helsinki-invites-international-companies-to-explore-rd-partnerships-in-life-sciences-and-ai–deep-tech-302789886.html

SOURCE Helsinki Partners

Continue Reading

Technology

Corrata Reimagines Mobile Device Security for the AI Era

Published

on

By

Company investing in bespoke on-device LLM for privacy-compliant mobile threat detection as AI reshapes the attack landscape

DUBLIN and LONDON, June 3, 2026 /PRNewswire/ — Infosec Europe, ExCeL London — Corrata, the mobile endpoint security company, today announced a comprehensive reimagining of its approach to mobile device security in response to the rapid transformation of the threat landscape by artificial intelligence. The announcement encompasses new AI governance capabilities, enhanced data loss prevention, and a commitment to developing a bespoke on-device large language model (LLM) for next-generation mobile threat detection.

 

 

“The device in your employee’s pocket is simultaneously connected to AI tools, targeted by AI-powered attackers, and operating in an environment where the threat landscape is being rewritten in real time,” said Colm Healy, CEO of Corrata. “The controls deployed two or three years ago were not built for this world. We have rebuilt ours to match it.”

How AI Is Reshaping the Mobile Threat Landscape

Mobile devices sit at the epicentre of three distinct AI-driven risk dimensions that security teams must now contend with simultaneously.

Hyper-personalised social engineering. AI has transformed phishing from a numbers game into targeted precision. Attackers now use large language models to construct lures from publicly available data, producing messages indistinguishable from genuine communications. Research puts the click-through rate on AI-generated phishing at 54%, against 12% for traditional campaigns. On mobile, where 85% of phishing attacks already occur outside email, across SMS, WhatsApp, Teams and other messaging channels, the impact is acute.

AI-accelerated exploits. In May 2026, Google Threat Intelligence Group confirmed a real-world threat actor had used a zero-day exploit developed with AI, planned for mass exploitation and only stopped by proactive counter-discovery. Finding and weaponising vulnerabilities no longer requires deep expertise or months of effort. The median time from disclosure to active exploitation had already fallen from 771 days in 2018 to single-digit hours before frontier AI models entered the picture. Mobile is particularly exposed, where apps are deployed quickly and sometimes outside the review processes that govern traditional software.

Shadow AI and data loss. When employees find that an AI tool makes them more productive, they use it, approved or not. Research suggests 43% of employees share corporate data with LLMs without authorisation. On mobile, where personal and professional boundaries are already blurred, the exposure is acute: sensitive documents uploaded to consumer AI services, client details pasted into chatbots, proprietary code submitted for debugging. Institutional knowledge is leaving organisations at an unprecedented rate, with no visibility and no controls in place.

How Corrata Is Responding

Corrata has always been built on a simple premise: mobile devices deserve the same depth of security monitoring as laptops and servers. Its on-device architecture inspects 100% of network traffic without routing it through a cloud relay, a visibility advantage no competitor has matched. In the AI era, that foundation becomes more important, not less. Corrata has now extended it across three areas.

On-device LLM for enhanced threat detection. The vast majority of mobile traffic is now encrypted, and current detection methods will struggle against the more sophisticated social engineering and exploit techniques that AI is enabling. Corrata is developing a custom on-device LLM purpose-built for the mobile environment. It will analyse traffic patterns, behavioural signals and connection metadata to surface threats hidden within encrypted sessions, on the device itself, in real time, with no data leaving the phone.

AI governance for the mobile workspace. Corrata’s AI Governance capability lets organisations define which AI services and SDKs are sanctioned in the mobile workspace and enforces those policies automatically. Approved tools are unaffected; access to unsanctioned services, including consumer chatbots, AI coding assistants and embedded LLM SDKs in third-party apps, is flagged or blocked. As AI governance frameworks including ISO 42001 and the EU AI Act mature, mobile is the enforcement gap most organisations have yet to close. Corrata closes it.

Precision mobile DLP for the AI age. Data leakage via mobile is no longer confined to lost devices or unencrypted email. AI tools are now a primary exfiltration channel. Corrata’s enhanced data loss prevention uses fine-grained traffic analysis to detect sensitive corporate data being transmitted to external services, whether deliberately or inadvertently, enabling security teams to act on genuine data loss events rather than chase false positives.

“Corrata brings together the deepest visibility into mobile traffic of any solution on the market with a new generation of AI-native capabilities built for the threats that matter most right now,” said Colm Healy.

Availability

Corrata’s AI Governance and enhanced DLP capabilities are available now. The on-device LLM is in active development, with availability to be announced. Organisations wishing to learn more or request a demonstration should visit corrata.com.

About Corrata

Corrata is a mobile endpoint security company headquartered in Dublin, Ireland. Its on-device technology delivers comprehensive threat detection and response for iOS and Android devices, combining advanced mobile threat defence with data loss prevention and AI governance. Corrata is a member of the Microsoft Intelligent Security Association (MISA), verified for use with FirstNet, and is accredited as ‘Cybersecurity Made in Europe’ by ECSO. For more information, visit corrata.com.

Logo: https://mma.prnewswire.com/media/2987647/Corrata_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/corrata-reimagines-mobile-device-security-for-the-ai-era-302785866.html

Continue Reading

Trending